These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9024267)

  • 1. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.
    Jaffe CA; DeMott-Friberg R; Frohman LA; Barkan AL
    J Clin Endocrinol Metab; 1997 Feb; 82(2):634-7. PubMed ID: 9024267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.
    Ocampo-Lim B; Guo W; DeMott-Friberg R; Barkan AL; Jaffe CA
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4396-9. PubMed ID: 8954048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous growth hormone-releasing hormone in acromegaly.
    Dimaraki EV; Chandler WF; Brown MB; Jaffe CA; Kim SY; Taussig R; Padmanabhan V; Barkan AL
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2185-90. PubMed ID: 16537684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.
    Pandya N; DeMott-Friberg R; Bowers CY; Barkan AL; Jaffe CA
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1186-9. PubMed ID: 9543138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
    Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
    J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.
    Jaffe CA; Friberg RD; Barkan AL
    J Clin Invest; 1993 Aug; 92(2):695-701. PubMed ID: 8349808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella.
    Osella G; Orlandi F; Caraci P; Ventura M; Deandreis D; Papotti M; Bongiovanni M; Angeli A; Terzolo M
    J Endocrinol Invest; 2003 Feb; 26(2):163-9. PubMed ID: 12739745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
    Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
    Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between growth hormone responses after growth hormone-releasing hormone (GHRH) and insulin hypoglycemia in ectopic GHRH syndrome.
    Popović V; Micić D; Damjanović S; Petakov M; Manojlović D; Mićić J
    Endocrinol Exp; 1990 Mar; 24(1-2):167-73. PubMed ID: 2113855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
    Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
    J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.